Submissions from 2018
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha
(OA13) Stereotactic Radiosurgery and Concurrent Targeted Therapy: Improving the Response Rate for Breast Cancer Brain Metastasis, Rupesh Kotecha
Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha
Recent advances in managing brain metastasis, Rupesh Kotecha and Minesh Mehta
Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta
Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis, Minesh Mehta
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539, Minesh Mehta
Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation, Minesh Mehta
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02, Minesh Mehta
Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms, Minesh Mehta
Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations, Minesh Mehta
The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists, Minesh Mehta
Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta
What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta
Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?, Minesh Mehta and Rupesh Kotecha
Adaptive planning and toxicities of uniform scanning proton therapy for lung cancer patients, Suresh Rana
Dosimetric Impact of Large Displacement of the Metal Port of the Tissue Expander in Intensity Modulated Proton Therapy, Jen Yu, Jaafar Bennouna, and Minesh Mehta
Submissions from 2017
Fixed Workstation versus Workstations on Wheels in the Emergency Department, Ariel Bowers, Razvan Buricel, Andrea Jimenez, Stefanie Moses, Yandro Perez Trevieso, and Juan Ramirez
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee, Michael Chuong
The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta
Comparison of initial patient setup accuracy between surface imaging and three point localization: A retrospective analysis, Alonso Gutierrez
MBA degree is needed for leadership roles in Medical Physics profession, Alonso Gutierrez
Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta
Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials, Minesh Mehta
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta
Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta
State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta
The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta
The role of radiation in treating glioblastoma: here to stay, Minesh Mehta
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong
Radiation Therapy for Liver Tumors: The State-of-the-art, Miguel Perez and Michael Chuong
Submissions from 2016
HPV-Associated Oropharyngeal Cancer: Changing Treatment Paradigm & Prognosis, Andre Abitbol
Reconciling Reimbursement for Proton Therapy, John Kerstiens
An overview of modern proton therapy, Minesh Mehta
Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer, Minesh Mehta
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review, Minesh Mehta
Clinical ramifications of "genomic staging" of low-grade gliomas, Minesh Mehta
International Medical Graduates in Radiation Oncology: Historical Trends and Comparison With Other Medical Specialties, Minesh Mehta
Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study, Minesh Mehta
Reply to M.C. Chamberlain, Minesh Mehta
Stereotactic Radiosurgery for Treatment of Brain Metastases, Minesh Mehta
Submissions from 2014
Predictors of radiotherapy-related GI toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529, Andre Abitbol
Indications of Radiosurgery in Palliative Care: A New Paradigm, Beatriz Amendola
Radiosurgery for Brain Metastases vs. Whole-Brain Radiation Update, Beatriz Amendola
Radiosurgery in Intracranial and Extracranial Schwannomas., Beatriz Amendola
Radiosurgery in Intracranial and Spine Shwannomas, Beatriz Amendola
The Future of Radiosurgery, Beatriz Amendola
Submissions from 2013
Advances in Radiation Oncology in Lung Cancer, Beatriz Amendola
Applications of VMAT Radiosurgery in Extracranial Disease, Beatriz Amendola
ASTRO Highlights in Spanish: Extreme Hypofractionation Cost-Effectiveness, Beatriz Amendola
Ductal Carcinoma In-Situ Treated With Accelerated Partial Breast Irradiation: 10-Year Results in a Single Institution, Beatriz Amendola
Early Breast Cancer Radiation Therapy Prone Position, Beatriz Amendola
Extreme Hypofractionation Cost-Effectiveness in the United States, Beatriz Amendola
Implementation of Extracranial Radiosurgery in the United States, Beatriz Amendola
Management of Oligometastasis, Beatriz Amendola
Radiation Therapy in Voluminous Breasts, Beatriz Amendola
Volumentric Arc Therapy in the Management of Primary and Metastatic Spine Tumors, Beatriz Amendola
Volumetric Arc Therapy in Early Breast Cancer, Beatriz Amendola
Volumetric Modulated Arc Therapy(VMAT) Reduces Treatment Time Compared to Conventional Intensity Modulated Radiation Treatment(IMRT) of Thoracic Tumors, Beatriz Amendola
Submissions from 2012
A New Radiation Technique for Bulky Tumors: Lattice Using Modern Technologies, Beatriz Amendola
DCIS of the Breast Treated with Balloon Brachytherapy: Seven Year Follow-up, Beatriz Amendola
Early Breast Cancer, Beatriz Amendola
Multidisciplinary Management of Lung Cancer: Radiotherapy, Beatriz Amendola
New Concepts in Management of Lung Adenocarcinoma: Radiotherapy, Beatriz Amendola
Partial Breast Irradiation: An Update, Beatriz Amendola
Pearls and Pitfalls of PET/CT, Beatriz Amendola
Radiosurgery in Oligometastases: SBRT Symposium, Beatriz Amendola
Radiosurgery in Spine Tumors, Beatriz Amendola
Rapid are Clinical Applications, Beatriz Amendola
Reunion with Experts: Radiotherapy Brain Tumors CNS/Re-Irradiation in Brain Metastases, Beatriz Amendola
Thymomas: Radiotherapy, Beatriz Amendola
Treatment of Brain Metastases from Breast Cancer: Can Whole-brain Irradiation (WBRT) Be Replaced by Radiosurgery?, Beatriz Amendola
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer, Alan Lewin, Robert Derhagopian, Andre Abitbol, D Jay Wieczorek, Vivek Mishra, and Lourdes Moreno
Submissions from 2007
Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife, William Brown, Alan Lewin, and Andre Abitbol
Submissions from 2005
Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol, Andre Abitbol, Alan Lewin, and Michael Troner
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma, Andre Abitbol, Alan Lewin, and Michael Troner